VASO-OCCLUSIVE CRISIS
Clinical trials for VASO-OCCLUSIVE CRISIS explained in plain language.
Never miss a new study
Get alerted when new VASO-OCCLUSIVE CRISIS trials appear
Sign up with your email to follow new studies for VASO-OCCLUSIVE CRISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in cutting sickle cell pain attacks
Disease control CompletedThis study tested a drug called inclacumab in 241 people with sickle cell disease who often have painful vaso-occlusive crises. The drug aims to block a protein that helps blood cells stick together, reducing the number of pain episodes. Participants received either inclacumab or…
Matched conditions: VASO-OCCLUSIVE CRISIS
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Oxygen therapy may ease sickle cell pain
Symptom relief CompletedThis study tested whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen therapy) can reduce pain and shorten hospital stays for adults with sickle cell disease who are having a pain crisis. Eight adults with uncomplicated pain crises received 1-3 sessions of t…
Matched conditions: VASO-OCCLUSIVE CRISIS
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated May 01, 2026 16:01 UTC